Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure
- PMID: 4009506
Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure
Abstract
Pigeons were trained to discriminate among i.m. injections of morphine (5.6 mg/kg), saline and naltrexone (10.0 mg/kg) in a three-key operant procedure with food reinforcement. Animals acquired the discrimination; each training condition occasioned responding on the injection-appropriate key, and the effects of morphine and naltrexone were dose-dependent. The opiate agonists ethylketazocine, buprenorphine and pentazocine substituted completely for morphine, and the opiate antagonist naloxone substituted completely for naltrexone. Meperidine, dextrorphan, beta-funaltrexamine, diprenorphine and nalorphine produced responding predominantly on the saline key, indicating that these compounds do not share completely discriminative properties with naltrexone or morphine in the pigeon. Small doses of naltrexone (0.01 and 0.1 mg/kg) shifted the morphine discrimination dose-effect curve in parallel to the right, without producing naltrexone-appropriate responding. Larger doses of naltrexone (1.0-10.0 mg/kg) prevented the discriminative effect of morphine and generated dose-dependent naltrexone-appropriate responding. The prior administration of small doses of morphine (0.1 and 1.0 mg/kg) enhanced the discriminative effects of naltrexone. Some dose combinations of naltrexone and morphine produced responding on all three keys, up to doses that suppressed behavior. The study of agonist-antagonist interactions may be aided by the use of these procedures, as descriptions of insurmountable antagonism may be complemented by the identification of stimulus conditions associated with the antagonist, as well as those conditions that represent novel stimulus states.
Similar articles
-
Morphine, saline and naltrexone discrimination in morphine-treated pigeons.J Pharmacol Exp Ther. 1987 Jul;242(1):195-202. J Pharmacol Exp Ther. 1987. PMID: 3612524
-
Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine.J Pharmacol Exp Ther. 1984 Sep;230(3):652-7. J Pharmacol Exp Ther. 1984. PMID: 6206224
-
Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.J Pharmacol Exp Ther. 1988 Feb;244(2):599-605. J Pharmacol Exp Ther. 1988. PMID: 3346837
-
Limitations on the antagonistic actions of opioid antagonists.Fed Proc. 1982 May;41(7):2333-8. Fed Proc. 1982. PMID: 7042396 Review.
-
Measuring naloxone antagonism of discriminative opioid stimulus.Fed Proc. 1982 May;41(7):2319-22. Fed Proc. 1982. PMID: 7042395 Review.
Cited by
-
Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.Psychopharmacology (Berl). 2003 May;167(2):203-10. doi: 10.1007/s00213-002-1367-9. Epub 2003 Mar 18. Psychopharmacology (Berl). 2003. PMID: 12644889
-
Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.Psychopharmacology (Berl). 1989;98(1):1-19. doi: 10.1007/BF00442000. Psychopharmacology (Berl). 1989. PMID: 2498952 No abstract available.
-
Drug discrimination by humans compared to nonhumans: current status and future directions.Psychopharmacology (Berl). 1993;111(3):259-70. doi: 10.1007/BF02244940. Psychopharmacology (Berl). 1993. PMID: 7870962 Review.
-
Drug discrimination procedures: differential characteristics of the drug A vs drug B and the drug A vs drug B vs no drug cases.Psychopharmacology (Berl). 1986;90(3):341-6. doi: 10.1007/BF00179188. Psychopharmacology (Berl). 1986. PMID: 3097722
-
Diprenorphine and naloxone in squirrel monkeys with enhanced sensitivity to opioid antagonists.Psychopharmacology (Berl). 1988;95(3):339-43. doi: 10.1007/BF00181944. Psychopharmacology (Berl). 1988. PMID: 3137619